Latest filing published 30 May 2007 for Vertex Pharmaceuticals INC / MA, €99k.
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -6.3%Entry US$31.44 · Close at T+365 US$29.47
- -21.6%Entry US$35.89 · Close at T+365 US$28.12
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Eve Elizabeth Slater: trading record in brief
Eve Elizabeth Slater discloses dealings in 2 companies, chiefly Phase Forward Inc and Vertex Pharmaceuticals INC / MA. The record holds 8 filings, for trades running from 23 March 2006 to 29 May 2007.
Market trades split into 6 purchases (€48k) and 1 sale (€226k). On balance, insiders were net sellers of €178k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 1 option exercise. In 2007 alone, the filings show 4 purchases and 1 sale.
Half of the purchases are above €6,200 and half below.
The latest filing, published on 30 May 2007, reports an option exercise of €99k in Vertex Pharmaceuticals INC / MA. The last insider purchase was made public on 28 February 2007, 7,194 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Eve Elizabeth Slater
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$13.32Common StockSEC:0000875320-07-000056:0
- 10,000 shares@ US$30.42Common StockSEC:0000875320-07-000056:1
- 400 shares@ US$13.46Common StockSEC:0001072613-07-000543:0Canonical exit: 27 May 2007 (T+90)
- 200 shares@ US$13.48Common StockSEC:0001072613-07-000543:1Canonical exit: 27 May 2007 (T+90)
- 287 shares@ US$13.49Common StockSEC:0001072613-07-000543:2Canonical exit: 27 May 2007 (T+90)
- 813 shares@ US$13.50Common StockSEC:0001072613-07-000543:3Canonical exit: 27 May 2007 (T+90)
- 455 shares@ US$31.98Common StockSEC:0000875320-06-000052:0Canonical exit: 15 Aug 2006 (T+90)
- 650 shares@ US$36.00Common StockSEC:0000875320-06-000032:0Canonical exit: 21 Jun 2006 (T+90)
8 of 8 declarations
